drugset / Trial / NCT06275841

A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant

NCT06275841

Phase 1 Completed 12 enrolled Pfizer Arvinas Estrogen Receptor, Inc. · collab
NaCrossoverOpen-labelOther

Summary

The purpose of the study is to investigate the effect of multiple doses of a proton-pump inhibitor (PPI) esomeprazole on the PK of vepdegestrant under fed conditions in healthy adult participants. All participants in this study will receive one dose of vepdegestrant alone by mouth in Period 1. In Period 2, everyone will receive esomeprazole by mouth once a day for multiple days. Participants will also receive one dose of vepdegestrant by mouth. The levels of vepdegestrant in Period 1 will be compared to the levels of vepdegestrant in Period 2 to determine if the PPI affects how vepdegestrant is processed differently in healthy adults.

Timeline

Start
2024-02-23
Primary completion
2024-05-03
Completion
2024-05-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule Oral
Subject vepdegestrant Other / unclassified Oral

Indications

No indication recorded.